Diamante Biotechnology: The Women Rewriting the Future of Autoimmune Healing
10 FINALIST - II Entrepreneurship Call 2025: Women in Technology
When Valentina Garonzi, Linda Avesani and Roberta Zampieri looked at the way autoimmune diseases were being treated, they saw a system that had remained unchanged for decades. Treatments that only alleviated symptoms. Therapies that weakened the immune system instead of retraining it. And millions of patients living with daily pain, uncertainty and chronic side effects.
So they asked a bold question:
What if the body could be taught to heal itself safely, sustainably, and with science rooted in nature?
From that question, Diamante Biotechnology was born.
Diamante Founders
A New Kind of Biotechnology, Grown in Plants
Based in Italy, Diamante is pioneering an entirely new approach to immunotherapy, one that uses plants as clean, sustainable biofactories to produce next-generation treatments.
Their technology is as simple as it is revolutionary:
plants produce viral nanoparticles, those nanoparticles carry disease-specific peptides, and once administered, they re-educate the immune system to stop attacking the body’s own tissues.
No suppression. No toxicity.
Just science guiding the immune system back to balance.
Diamante’s work focuses on diseases such as rheumatoid arthritis, lupus, and multiple sclerosis, offering hope to patients who currently have limited long-term solutions.
What Makes Diamante So Transformative
1. A Sustainable Platform with Global Potential
Using plants instead of traditional lab systems allows for cleaner, faster and more cost-effective drug production with dramatically lower environmental impact.
2. A New Way to Treat Autoimmune Diseases
Their therapy doesn’t silence the immune system; it teaches it.
By inducing immune tolerance, Diamante’s approach avoids the often severe side effects of conventional treatments.
3. Strong Scientific Results
Across five preclinical studies in rheumatoid arthritis models, Diamante’s therapy achieved complete remission of symptoms outperforming standard treatments, with zero toxicity.
4. Protected Innovation
With six patent families across the EU, U.S. and Israel, Diamante has built a solid intellectual property foundation for scaling their platform.
5. A Mission Backed by Results
The team has already secured €4.5 million in funding through equity and grants, alongside international recognition and collaborations with leading clinical and biotech partners.
Why Diamante Matters
Autoimmune diseases affect hundreds of millions of people worldwide. Current treatments often come at a high cost: vulnerability to infections, long-term toxicity, and limited effectiveness.
Diamante offers something radically different:
a therapy that empowers the immune system instead of disabling it produced sustainably, affordably, and with scientific rigor.
Their work has the potential to reduce healthcare costs, improve patients' quality of life, and shift the global conversation about how we treat chronic immune conditions.
We are proud to celebrate DIAMANTE, awarded second place in the Women in Technology II Entrepreneurship Call 2025 by Tara for Women.
Congratulations to the incredible team your vision, dedication, and innovation inspire us all, and we can’t wait to see how your journey continues to make an impact!